Literature DB >> 21354639

Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center.

Ga Yeon Lee1, Shin Yi Jang, Sung Min Ko, Eun Kyoung Kim, Sung Ho Lee, Hyejin Han, Seung Hyuk Choi, Young-Wook Kim, Yeon Hyeon Choe, Duk-Kyung Kim.   

Abstract

Takayasu's arteritis (TA) is primary vasculitis. Cardiac involvements in TA is due to the consequences of the vascular lesions as well as the primary pathology of the heart. The disease activity of TA is known to influence the prognosis of TA. We hypothesized that the cardiovascular involvement of TA is related to the disease activity. We evaluated the cardiovascular manifestations of TA, and we assessed their relation to the disease activity of TA. Two hundred four patients were diagnosed with TA from September, 1994 to March, 2009 according to the diagnostic criteria of the 1990 American College of Rheumatology. Their clinical features and the laboratory, angiographic and echocardiographic findings were retrospectively reviewed. The group with active disease activity was defined as satisfying one of the following criteria: i) an elevated ESR or CRP level, ii) thickened arterial wall with mural enhancement on CT or MR angiography, and iii) carotidynia at the time of the initial diagnosis. One hundred thirty nine patients (69.2%) were classified as the active group. The cardiovascular signs and symptoms were not generally different between the active and inactive groups. The active TA patients had more frequent involvement of the ascending aorta and the aortic arch and its main branches than did the inactive group. The active group showed a higher incidence of significant aortic valve regurgitation and pulmonary hypertension, and a higher level of NT-proBNP. These findings suggest that disease activity plays an important role for the cardiovascular manifestations of TA. The TA patients with higher activity have more cardiovascular morbidity compared to the TA patients with low disease activity.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21354639     DOI: 10.1016/j.ijcard.2011.01.094

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  33 in total

Review 1.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

2.  Anti-cytokine treatment for Takayasu arteritis: State of the art.

Authors:  Enrico Tombetti; Maria Chiara Di Chio; Silvia Sartorelli; Enrica Bozzolo; Maria Grazia Sabbadini; Angelo A Manfredi; Elena Baldissera
Journal:  Intractable Rare Dis Res       Date:  2014-02

3.  Takayasu arteritis with multiple coronary involvement and early graft relapse.

Authors:  Leonardo Miranda Macedo; Neiberg de Alcantara Lima; Ricardo Lessa de Castro Junior; Susan Faragher Bannon
Journal:  BMJ Case Rep       Date:  2019-04-30

4.  Takayasu arteritis: imaging spectrum at multidetector CT angiography.

Authors:  F P Zhu; S Luo; Z J Wang; Z Y Jin; L J Zhang; G M Lu
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

Review 5.  Recent advances in Takayasu's arteritis.

Authors:  Fatma Alibaz-Öner; Sibel Zehra Aydın; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2015-03-01

6.  Cardiothoracic surgery and peripheral endovascular intervention in cardiovascular damage from a cohort of orphan rheumatological diseases-epidemiological and survival analysis.

Authors:  Maria Elena Soto; Huitzilihuitl Saucedo-Orozco; Eric Ochoa-Hein; Guering Eid-Lidt; Javier E Anaya-Ayala; Israel Pérez-Torres; Solange Gabriela Koretzky; Pedro A Reyes; Edison Ricardo Espinoza-Saquicela; Ivan Hernandez; Humberto Martinez-Hernandez
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

7.  Aortic valve replacement surgery for a case of infantile Takayasu arteritis.

Authors:  Hye Won Kwon; Yoon Jung Suh; Ji Seok Bang; Bo Sang Kwon; Gi Beom Kim; Eun Jung Bae; Woong Han Kim; Chung Il Noh
Journal:  Korean J Pediatr       Date:  2012-07-17

Review 8.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

9.  Cardiac manifestations of rheumatological conditions: a narrative review.

Authors:  Mohammad Bagher Owlia; Seyed Mohammad Yousof Mostafavi Pour Manshadi; Nafiseh Naderi
Journal:  ISRN Rheumatol       Date:  2012-10-17

10.  Multimeric stability of human C-reactive protein in archived specimens.

Authors:  Qiling Li; Ting Kang; Xiaohua Tian; Yamin Ma; Min Li; Jendai Richards; Tameka Bythwood; Yueling Wang; Xu Li; Dong Liu; Li Ma; Qing Song
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.